The global Rituximab Biosimilars market was valued at US$ 2.284 billion in 2023 and is projected to reach US$ 6.065 billion by 2029, at a CAGR of 12.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Rituximab Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rituximab Biosimilars. This report contains market size and forecasts of Rituximab Biosimilars in global, including the following market information:
- Global Rituximab Biosimilars Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Rituximab Biosimilars Market Sales, 2018-2023, 2024-2030, (K Units)
- Global top five Rituximab Biosimilars companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
500mg Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Rituximab Biosimilars include Amgen, AryoGen Pharmed, Biocad, Cadila Pharmaceuticals, Celltrion, Dr Reddys Laboratories, Teva, Hetero Group and Innovent Biologics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rituximab Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rituximab Biosimilars Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Rituximab Biosimilars Market Segment Percentages, by Type, 2023 (%)
Global Rituximab Biosimilars Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Rituximab Biosimilars Market Segment Percentages, by Application, 2023 (%)
- Hospital Pharmacy
- Retail Pharmacy
Global Rituximab Biosimilars Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Rituximab Biosimilars Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rituximab Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Rituximab Biosimilars revenues share in global market, 2023 (%)
- Key companies Rituximab Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Rituximab Biosimilars sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen
- AryoGen Pharmed
- Biocad
- Cadila Pharmaceuticals
- Celltrion
- Dr Reddys Laboratories
- Teva
- Hetero Group
- Innovent Biologics
- Intas Biopharmaceuticals
- Mylan
- Probiomed
- TRPharma
- Zenotech Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rituximab Biosimilars, market overview.
Chapter 2: Global Rituximab Biosimilars market size in revenue and volume.
Chapter 3: Detailed analysis of Rituximab Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rituximab Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rituximab Biosimilars capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rituximab Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rituximab Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rituximab Biosimilars Overall Market Size
2.1 Global Rituximab Biosimilars Market Size: 2022 VS 2029
2.2 Global Rituximab Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rituximab Biosimilars Sales: 2018-2029
3 Company Landscape
3.1 Top Rituximab Biosimilars Players in Global Market
3.2 Top Global Rituximab Biosimilars Companies Ranked by Revenue
3.3 Global Rituximab Biosimilars Revenue by Companies
3.4 Global Rituximab Biosimilars Sales by Companies
3.5 Global Rituximab Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rituximab Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rituximab Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rituximab Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Rituximab Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Rituximab Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Rituximab Biosimilars Market Size Markets, 2022 & 2029
4.1.2 500mg
4.1.3 100mg
4.1.4 Other
4.2 By Type - Global Rituximab Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Rituximab Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Rituximab Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Rituximab Biosimilars Revenue Market Share, 2018-2029
4.3 By Type - Global Rituximab Biosimilars Sales & Forecasts
4.3.1 By Type - Global Rituximab Biosimilars Sales, 2018-2023
4.3.2 By Type - Global Rituximab Biosimilars Sales, 2024-2029
4.3.3 By Type - Global Rituximab Biosimilars Sales Market Share, 2018-2029
4.4 By Type - Global Rituximab Biosimilars Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rituximab Biosimilars Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.2 By Application - Global Rituximab Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Rituximab Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Rituximab Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Rituximab Biosimilars Revenue Market Share, 2018-2029
5.3 By Application - Global Rituximab Biosimilars Sales & Forecasts
5.3.1 By Application - Global Rituximab Biosimilars Sales, 2018-2023
5.3.2 By Application - Global Rituximab Biosimilars Sales, 2024-2029
5.3.3 By Application - Global Rituximab Biosimilars Sales Market Share, 2018-2029
5.4 By Application - Global Rituximab Biosimilars Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Rituximab Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Rituximab Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Rituximab Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Rituximab Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Rituximab Biosimilars Revenue Market Share, 2018-2029
6.3 By Region - Global Rituximab Biosimilars Sales & Forecasts
6.3.1 By Region - Global Rituximab Biosimilars Sales, 2018-2023
6.3.2 By Region - Global Rituximab Biosimilars Sales, 2024-2029
6.3.3 By Region - Global Rituximab Biosimilars Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Rituximab Biosimilars Revenue, 2018-2029
6.4.2 By Country - North America Rituximab Biosimilars Sales, 2018-2029
6.4.3 US Rituximab Biosimilars Market Size, 2018-2029
6.4.4 Canada Rituximab Biosimilars Market Size, 2018-2029
6.4.5 Mexico Rituximab Biosimilars Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Rituximab Biosimilars Revenue, 2018-2029
6.5.2 By Country - Europe Rituximab Biosimilars Sales, 2018-2029
6.5.3 Germany Rituximab Biosimilars Market Size, 2018-2029
6.5.4 France Rituximab Biosimilars Market Size, 2018-2029
6.5.5 U.K. Rituximab Biosimilars Market Size, 2018-2029
6.5.6 Italy Rituximab Biosimilars Market Size, 2018-2029
6.5.7 Russia Rituximab Biosimilars Market Size, 2018-2029
6.5.8 Nordic Countries Rituximab Biosimilars Market Size, 2018-2029
6.5.9 Benelux Rituximab Biosimilars Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Rituximab Biosimilars Revenue, 2018-2029
6.6.2 By Region - Asia Rituximab Biosimilars Sales, 2018-2029
6.6.3 China Rituximab Biosimilars Market Size, 2018-2029
6.6.4 Japan Rituximab Biosimilars Market Size, 2018-2029
6.6.5 South Korea Rituximab Biosimilars Market Size, 2018-2029
6.6.6 Southeast Asia Rituximab Biosimilars Market Size, 2018-2029
6.6.7 India Rituximab Biosimilars Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Rituximab Biosimilars Revenue, 2018-2029
6.7.2 By Country - South America Rituximab Biosimilars Sales, 2018-2029
6.7.3 Brazil Rituximab Biosimilars Market Size, 2018-2029
6.7.4 Argentina Rituximab Biosimilars Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rituximab Biosimilars Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Rituximab Biosimilars Sales, 2018-2029
6.8.3 Turkey Rituximab Biosimilars Market Size, 2018-2029
6.8.4 Israel Rituximab Biosimilars Market Size, 2018-2029
6.8.5 Saudi Arabia Rituximab Biosimilars Market Size, 2018-2029
6.8.6 UAE Rituximab Biosimilars Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Rituximab Biosimilars Major Product Offerings
7.1.4 Amgen Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 AryoGen Pharmed
7.2.1 AryoGen Pharmed Company Summary
7.2.2 AryoGen Pharmed Business Overview
7.2.3 AryoGen Pharmed Rituximab Biosimilars Major Product Offerings
7.2.4 AryoGen Pharmed Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 AryoGen Pharmed Key News & Latest Developments
7.3 Biocad
7.3.1 Biocad Company Summary
7.3.2 Biocad Business Overview
7.3.3 Biocad Rituximab Biosimilars Major Product Offerings
7.3.4 Biocad Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Biocad Key News & Latest Developments
7.4 Cadila Pharmaceuticals
7.4.1 Cadila Pharmaceuticals Company Summary
7.4.2 Cadila Pharmaceuticals Business Overview
7.4.3 Cadila Pharmaceuticals Rituximab Biosimilars Major Product Offerings
7.4.4 Cadila Pharmaceuticals Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Cadila Pharmaceuticals Key News & Latest Developments
7.5 Celltrion
7.5.1 Celltrion Company Summary
7.5.2 Celltrion Business Overview
7.5.3 Celltrion Rituximab Biosimilars Major Product Offerings
7.5.4 Celltrion Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Celltrion Key News & Latest Developments
7.6 Dr Reddy?s Laboratories
7.6.1 Dr Reddy?s Laboratories Company Summary
7.6.2 Dr Reddy?s Laboratories Business Overview
7.6.3 Dr Reddy?s Laboratories Rituximab Biosimilars Major Product Offerings
7.6.4 Dr Reddy?s Laboratories Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Dr Reddy?s Laboratories Key News & Latest Developments
7.7 Teva
7.7.1 Teva Company Summary
7.7.2 Teva Business Overview
7.7.3 Teva Rituximab Biosimilars Major Product Offerings
7.7.4 Teva Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Teva Key News & Latest Developments
7.8 Hetero Group
7.8.1 Hetero Group Company Summary
7.8.2 Hetero Group Business Overview
7.8.3 Hetero Group Rituximab Biosimilars Major Product Offerings
7.8.4 Hetero Group Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Hetero Group Key News & Latest Developments
7.9 Innovent Biologics
7.9.1 Innovent Biologics Company Summary
7.9.2 Innovent Biologics Business Overview
7.9.3 Innovent Biologics Rituximab Biosimilars Major Product Offerings
7.9.4 Innovent Biologics Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 Innovent Biologics Key News & Latest Developments
7.10 Intas Biopharmaceuticals
7.10.1 Intas Biopharmaceuticals Company Summary
7.10.2 Intas Biopharmaceuticals Business Overview
7.10.3 Intas Biopharmaceuticals Rituximab Biosimilars Major Product Offerings
7.10.4 Intas Biopharmaceuticals Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Intas Biopharmaceuticals Key News & Latest Developments
7.11 Mylan
7.11.1 Mylan Company Summary
7.11.2 Mylan Rituximab Biosimilars Business Overview
7.11.3 Mylan Rituximab Biosimilars Major Product Offerings
7.11.4 Mylan Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 Mylan Key News & Latest Developments
7.12 Probiomed
7.12.1 Probiomed Company Summary
7.12.2 Probiomed Rituximab Biosimilars Business Overview
7.12.3 Probiomed Rituximab Biosimilars Major Product Offerings
7.12.4 Probiomed Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Probiomed Key News & Latest Developments
7.13 TRPharma
7.13.1 TRPharma Company Summary
7.13.2 TRPharma Rituximab Biosimilars Business Overview
7.13.3 TRPharma Rituximab Biosimilars Major Product Offerings
7.13.4 TRPharma Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 TRPharma Key News & Latest Developments
7.14 Zenotech Laboratories
7.14.1 Zenotech Laboratories Company Summary
7.14.2 Zenotech Laboratories Business Overview
7.14.3 Zenotech Laboratories Rituximab Biosimilars Major Product Offerings
7.14.4 Zenotech Laboratories Rituximab Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Zenotech Laboratories Key News & Latest Developments
8 Global Rituximab Biosimilars Production Capacity, Analysis
8.1 Global Rituximab Biosimilars Production Capacity, 2018-2029
8.2 Rituximab Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Rituximab Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rituximab Biosimilars Supply Chain Analysis
10.1 Rituximab Biosimilars Industry Value Chain
10.2 Rituximab Biosimilars Upstream Market
10.3 Rituximab Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rituximab Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Rituximab Biosimilars in Global Market
Table 2. Top Rituximab Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Rituximab Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Rituximab Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global Rituximab Biosimilars Sales by Companies, (K Units), 2018-2023
Table 6. Global Rituximab Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Rituximab Biosimilars Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Rituximab Biosimilars Product Type
Table 9. List of Global Tier 1 Rituximab Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rituximab Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rituximab Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Rituximab Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Rituximab Biosimilars Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Rituximab Biosimilars Sales (K Units), 2018-2023
Table 15. By Type - Global Rituximab Biosimilars Sales (K Units), 2024-2029
Table 16. By Application ? Global Rituximab Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Rituximab Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Rituximab Biosimilars Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Rituximab Biosimilars Sales (K Units), 2018-2023
Table 20. By Application - Global Rituximab Biosimilars Sales (K Units), 2024-2029
Table 21. By Region ? Global Rituximab Biosimilars Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Rituximab Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Rituximab Biosimilars Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Rituximab Biosimilars Sales (K Units), 2018-2023
Table 25. By Region - Global Rituximab Biosimilars Sales (K Units), 2024-2029
Table 26. By Country - North America Rituximab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Rituximab Biosimilars Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Rituximab Biosimilars Sales, (K Units), 2018-2023
Table 29. By Country - North America Rituximab Biosimilars Sales, (K Units), 2024-2029
Table 30. By Country - Europe Rituximab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Rituximab Biosimilars Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Rituximab Biosimilars Sales, (K Units), 2018-2023
Table 33. By Country - Europe Rituximab Biosimilars Sales, (K Units), 2024-2029
Table 34. By Region - Asia Rituximab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Rituximab Biosimilars Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Rituximab Biosimilars Sales, (K Units), 2018-2023
Table 37. By Region - Asia Rituximab Biosimilars Sales, (K Units), 2024-2029
Table 38. By Country - South America Rituximab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Rituximab Biosimilars Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Rituximab Biosimilars Sales, (K Units), 2018-2023
Table 41. By Country - South America Rituximab Biosimilars Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Rituximab Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Rituximab Biosimilars Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Rituximab Biosimilars Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Rituximab Biosimilars Sales, (K Units), 2024-2029
Table 46. Amgen Company Summary
Table 47. Amgen Rituximab Biosimilars Product Offerings
Table 48. Amgen Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. AryoGen Pharmed Company Summary
Table 51. AryoGen Pharmed Rituximab Biosimilars Product Offerings
Table 52. AryoGen Pharmed Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AryoGen Pharmed Key News & Latest Developments
Table 54. Biocad Company Summary
Table 55. Biocad Rituximab Biosimilars Product Offerings
Table 56. Biocad Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Biocad Key News & Latest Developments
Table 58. Cadila Pharmaceuticals Company Summary
Table 59. Cadila Pharmaceuticals Rituximab Biosimilars Product Offerings
Table 60. Cadila Pharmaceuticals Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Cadila Pharmaceuticals Key News & Latest Developments
Table 62. Celltrion Company Summary
Table 63. Celltrion Rituximab Biosimilars Product Offerings
Table 64. Celltrion Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Celltrion Key News & Latest Developments
Table 66. Dr Reddy?s Laboratories Company Summary
Table 67. Dr Reddy?s Laboratories Rituximab Biosimilars Product Offerings
Table 68. Dr Reddy?s Laboratories Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Dr Reddy?s Laboratories Key News & Latest Developments
Table 70. Teva Company Summary
Table 71. Teva Rituximab Biosimilars Product Offerings
Table 72. Teva Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Teva Key News & Latest Developments
Table 74. Hetero Group Company Summary
Table 75. Hetero Group Rituximab Biosimilars Product Offerings
Table 76. Hetero Group Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Hetero Group Key News & Latest Developments
Table 78. Innovent Biologics Company Summary
Table 79. Innovent Biologics Rituximab Biosimilars Product Offerings
Table 80. Innovent Biologics Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Innovent Biologics Key News & Latest Developments
Table 82. Intas Biopharmaceuticals Company Summary
Table 83. Intas Biopharmaceuticals Rituximab Biosimilars Product Offerings
Table 84. Intas Biopharmaceuticals Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Intas Biopharmaceuticals Key News & Latest Developments
Table 86. Mylan Company Summary
Table 87. Mylan Rituximab Biosimilars Product Offerings
Table 88. Mylan Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Mylan Key News & Latest Developments
Table 90. Probiomed Company Summary
Table 91. Probiomed Rituximab Biosimilars Product Offerings
Table 92. Probiomed Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Probiomed Key News & Latest Developments
Table 94. TRPharma Company Summary
Table 95. TRPharma Rituximab Biosimilars Product Offerings
Table 96. TRPharma Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. TRPharma Key News & Latest Developments
Table 98. Zenotech Laboratories Company Summary
Table 99. Zenotech Laboratories Rituximab Biosimilars Product Offerings
Table 100. Zenotech Laboratories Rituximab Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Zenotech Laboratories Key News & Latest Developments
Table 102. Rituximab Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Rituximab Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Rituximab Biosimilars Production by Region, 2018-2023 (K Units)
Table 105. Global Rituximab Biosimilars Production by Region, 2024-2029 (K Units)
Table 106. Rituximab Biosimilars Market Opportunities & Trends in Global Market
Table 107. Rituximab Biosimilars Market Drivers in Global Market
Table 108. Rituximab Biosimilars Market Restraints in Global Market
Table 109. Rituximab Biosimilars Raw Materials
Table 110. Rituximab Biosimilars Raw Materials Suppliers in Global Market
Table 111. Typical Rituximab Biosimilars Downstream
Table 112. Rituximab Biosimilars Downstream Clients in Global Market
Table 113. Rituximab Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Rituximab Biosimilars Segment by Type in 2022
Figure 2. Rituximab Biosimilars Segment by Application in 2022
Figure 3. Global Rituximab Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rituximab Biosimilars Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Rituximab Biosimilars Revenue, 2018-2029 (US$, Mn)
Figure 7. Rituximab Biosimilars Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rituximab Biosimilars Revenue in 2022
Figure 9. By Type - Global Rituximab Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 11. By Type - Global Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 12. By Type - Global Rituximab Biosimilars Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Rituximab Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 15. By Application - Global Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 16. By Application - Global Rituximab Biosimilars Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Rituximab Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Rituximab Biosimilars Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 20. By Region - Global Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 21. By Country - North America Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 22. By Country - North America Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 23. US Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 28. Germany Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 29. France Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 37. China Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 41. India Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 43. By Country - South America Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 44. Brazil Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Rituximab Biosimilars Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Rituximab Biosimilars Sales Market Share, 2018-2029
Figure 48. Turkey Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Rituximab Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 52. Global Rituximab Biosimilars Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Rituximab Biosimilars by Region, 2022 VS 2029
Figure 54. Rituximab Biosimilars Industry Value Chain
Figure 55. Marketing Channels
